Site specific HER2 antibody drug conjugates
US10689458B2 · kind B2 · utility
0Cited by
11References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 21, 2016 |
| Grant date | Jun 23, 2020 |
| Priority date | — |
| Expiry date | Apr 15, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides site specific HER2 antibody drug conjugates and methods for preparing and using the same.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.